The North America Light Therapy Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).
Light treatment employs a light box, which is significantly brighter than a typical bulb and emits up to 10,000 lux (a measure of light intensity) of light at a precise distance. They may also employ a lesser intensity of specific light wavelengths between the blue (460 nm) and green (525 nm) regions of the visible light spectrum.
A study suggests that the blue light frequently utilized for SAD treatment might need to be replaced by white or green illumination because of a possible engagement of cones in the suppression of melatonin. An earlier study demonstrated that green light therapy treatment at doses of 350 lux yields melatonin suppression as well as phase shifts comparable to 10,000 lux white light therapy.
Increased use of broadband and narrowband UV light therapy for the dermatological treatment of skin conditions has resulted in better outcomes, which has further augmented the demand for these therapies. Benefits offered by light therapy, like cellular regeneration and improved blood circulation, are anticipated to drive market growth. Additionally, the rising demand for minimally invasive or non-invasive treatments and improved awareness of light therapy methods will greatly raise market revenue.
Several therapeutic philosophies have been researched. The majority of SAD patients, between 60 and 80%, may benefit from daylight therapy, according to medical professionals. Due to the growth in cases of depression, light therapy is becoming more and more popular, drawing top-tier service providers. Moreover, over the course of the projected period, rising product approvals from regulatory bodies are anticipated to drive market expansion. For instance, in 2019, Health Canada granted Investigational Testing Approval (ITA) to ToeFX for its cutting-edge photodynamic treatment for onychomycosis. Therefore, the region is boosting the growth of the light therapy market due to the increased prevalence of various skin disorders.
The US market dominated the North America Light Therapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $323.8 million by 2028. The Canada market is poised to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.4% during (2022 - 2028).
Based on End-use, the market is segmented into Home Healthcare and Dermatology Clinics. Based on Application, the market is segmented into Sleeping Disorders, Eczema & Acne Vulgaris, Psoriasis, Vitiligo and Others. Based on Light Type, the market is segmented into Blue Light, Red Light and White Light. Based on Product, the market is segmented into Handheld Devices for Skin Treatment, Floor & Desk Lamps, Light Box, Light Therapy Lamps, Light Visor and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Light Therapy Market is Estimated to reach $1.2 Billion by 2028, at a CAGR of 4.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Beurer GmBH, Johnson & Johnson, Koninklijke Philips N.V., Biophotas, Inc. (Celluma), Nature Bright Company, Outside In (Cambridge) Ltd. (Lumie), Northern Light Technologies, Inc., Verilux, Inc. (Bear Down Brands, LLC), The Daylight Company Limited, and Theralight LLC.By End-use
By Application
By Light Type
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 